BAMF Health and Henry Ford Health Collaborate on Theranostics Center in Detroit
In a significant move for healthcare innovation, BAMF Health and Henry Ford Health have announced a strategic partnership to establish a Comprehensive Theranostics Center in downtown Detroit. This initiative, located at the Life Sciences Building on Bedrock’s Gratiot Site, aims to expand patient access to precision medicine and solidify Detroit’s reputation as a hub for medical advancement.
Partnership Overview and Implications
The collaboration merges BAMF Health’s leadership in theranostics with Henry Ford Health’s extensive experience in clinical excellence and community-centered care. This partnership will provide leading-edge services in molecular imaging, radiopharmaceutical therapy, and research, benefiting patients throughout Michigan and beyond.
Dr. Anthony Chang, CEO of BAMF Health, stated, “This world-changing partnership reflects a shared commitment to transforming how complex diseases are detected, treated, and managed. Together with Henry Ford Health, we will make precision medicine affordable and accessible to all while positioning Michigan as a national and global leader in healthcare delivery and innovation.”
Facility Details and Economic Impact
Set to be BAMF Health's second Comprehensive Theranostics Center, this facility follows the flagship center opened in Grand Rapids in 2022, which has set the gold standard in integrated precision medicine and radiopharmaceutical manufacturing. The new 45,000-square-foot center will feature:
- A molecular imaging clinic
- A molecular therapy clinic
- A commercial radiopharmacy supporting patient care and clinical research
As anchor tenants, BAMF Health and Henry Ford Health are positioned to boost the local economy, attract investments, foster workforce development, and enhance medical tourism in the state.
Expert Insights on Theranostics
Dr. Adnan Munkarah, Chief Physician Executive at Henry Ford Health, remarked, “Theranostics represents the next evolution in precision medicine, and it’s critical our patients have access to these highly targeted diagnostic and therapeutic options. BAMF Health emerged as the clear leader and ideal partner to expand access to molecular imaging and clinical research.”
As Henry Ford Health continues to advance its high-value care model, the partnership significantly enhances its objective to provide the right care at the right time and place.
Growth Strategy and Financial Aspects
BAMF Health’s VP of Partnerships, Laurie Placinski, noted, “Our partnership with Henry Ford Health exemplifies BAMF Health’s national growth strategy. By collaborating with mission-aligned health systems, we can ensure patients access world-class precision medicine close to home.”
The successful establishment of this partnership was facilitated by Hall Render as legal counsel to Henry Ford Health, Bass, Berry & Sims PLC for BAMF Health, and Ziegler as financial advisor.
About BAMF Health
BAMF Health is recognized as the world’s first vertically integrated platform for intelligence-based precision medicine. Headquartered in Grand Rapids, Michigan, the company utilizes advanced theranostic imaging technology to detect, treat cancer and other diseases while conducting clinical trials. Their mission is to empower patients to reclaim their lives through innovative healthcare solutions.
About Henry Ford Health
Henry Ford Health is a leading healthcare provider committed to enhancing people's lives. With over 550 sites across Michigan and a team of more than 50,000, they offer comprehensive services, from primary care to specialized health services. The organization is dedicated to health equity, contributing over $780 million annually in uncompensated care and community benefits.